Kim Boericke joins THREAD as Chief Delivery Officer

THREAD, a technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralised clinical trials (DCTs), today announced the appointment of Kim Boericke as chief delivery officer.

In this role, Boericke will lead the company’s Technology Enablement Consulting Services.

A 2021 Stevie Award winner for Female Executive of the Year, Boericke brings more than 25 years of experience in operations within the drug development industry, having designed, built and strategically evolved organisations throughout her career.

In her new role, Boericke will lead THREAD’s global team of consulting services experts focused on technology implementation for customers.

She will oversee operational design, launch and technology support to help scale THREAD’s unified patient-centric platform across the company’s expanding global portfolio.

“Our customers are focused on designing, operating and scaling the most patient-centric research,” said Boericke.

“I am thrilled to join THREAD’s team of experts focused on helping our customers deliver studies that reduce patient burden, better support sites and provide a more inclusive study design for patients around the world.”

Prior to joining THREAD, Boericke served in executive leadership positions at leading global contract research organisations and academic research organisations where she enabled sponsors to deliver their research programs through a combination of technology and consulting services.

Boericke also has been active in corporate initiatives focused on diversity, equity and inclusion, including as executive sponsor for the Network of Women (NOW) and PRIDE, and is currently an independent board director for the Mapi Research Trust.

“Kim brings senior-level operational expertise, customer focus and industry stakeholder views to THREAD,” said John Reites, CEO, THREAD.

“Her appointment represents an important addition to THREAD’s leadership team to enrich our market leadership position as we deliver the most patient-centric research approaches for our customers.”